In line with this, Yuan et al. revealed miR-155 as a target of the lncRNA CASC2: in particular, CASC2 was found to be downregulated in HCC tissue samples and was revealed to act as a molecular sponge inhibiting the expression of miR-155 [96]. This evidence concerns the gene CASC2 and hepatocellular carcinoma.